The related chemical compound
homatropine methylbromide (methylhomatropine) is a different medication. Homatropine is less
potent than
atropine and has a shorter duration of action. It is available as the
hydrobromidesalt. Homatropine is also given as an atropine substitute,[1] given to reverse the muscarinic and
CNS effects associated with indirect
cholinomimetic (anti-AChase) administration.
^Scharer LL, Burhenne HJ (April 1964). "Megacolon associated with administration of an anticholinergic drug in a patient with ulcerative colitis". The American Journal of Digestive Diseases. 9 (4): 268–274.
doi:
10.1007/bf02232133.
PMID14142388.
S2CID19169565.
^World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization.
hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
The related chemical compound
homatropine methylbromide (methylhomatropine) is a different medication. Homatropine is less
potent than
atropine and has a shorter duration of action. It is available as the
hydrobromidesalt. Homatropine is also given as an atropine substitute,[1] given to reverse the muscarinic and
CNS effects associated with indirect
cholinomimetic (anti-AChase) administration.
^Scharer LL, Burhenne HJ (April 1964). "Megacolon associated with administration of an anticholinergic drug in a patient with ulcerative colitis". The American Journal of Digestive Diseases. 9 (4): 268–274.
doi:
10.1007/bf02232133.
PMID14142388.
S2CID19169565.
^World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization.
hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.